Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14349 | Auristatin F | Microtubule Associated | Cytoskeletal Signaling |
Auristatin F 是一种有效的微管抑制剂和血管损伤剂。 Auristatin F 可用于抗体-药物偶联物。 | |||
T13278 |
Valecobulin hydrochloride
CKD-516 hydrochloride |
Microtubule Associated | Cytoskeletal Signaling |
Valecobulin hydrochloride (CKD-516 hydrochloride) 是 S516 的缬氨酸前体药和血管阻断剂。Valecobulin hydrochloride 对β-微管蛋白聚合有强效的抑制作用,对小鼠和人类的实体肿瘤具有显著的抗肿瘤活性。 | |||
T37024 |
Mca-DEVDAPK(Dnp)-OH
|
||
Mca-DEVDAPK(Dnp)-OH 是 caspase-3 的荧光底物。 | |||
T2511 |
Plinabulin
普那布林,NPI-2358 |
Microtubule Associated | Cytoskeletal Signaling |
Plinabulin (NPI-2358) 是一种抗微管蛋白解聚肿瘤细胞的血管破坏剂,选择性地靶向并结合到微管蛋白的秋水仙碱结合位点,从而中断微管动力学的平衡。它对人肿瘤细胞系具有抑制作用,对 HT-29 细胞系的IC50值为 9.8 nM。 | |||
T68273 |
BNC105P
|
||
BNC105P is a benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities. Upon administration vascular disrupting agent BNC105P, the disodium phosphate ester of BNC105, is rapidly converted to BNC105; in activated endothelial cells, BNC105 binds to tubulin and inhibits its polymerization, which may result in a blockage of mitotic spindle formation, cell cycle arrest, and disruption of the tumor vasculature. Hypoxic conditions ensue, deprivi... |